Takeover should be a minimum of $6 imo...If multiple offers $9/$10...might be better now to stay independent but imo Elliot & Mgt will take a good offer...either way stock ridiculously undervalued...
Ridiculous - the post marketing followup in EU and other trials make the Ph 3 a quick slam dunk...expect companies who Pfaffle has talked to about running the Ph 3 to suddenly want to take this company over - an unencumbered anti-microbial with no US competition until 2030+ and huge upside in Europe on legal settlement . Insanely low market cap here in the 2's.
Market Data 
Markets 
AI
